Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

The objective response rate (ORR) was 32% with adagrasib versus 9% with docetaxel (OR 4.68, 95% CI 2.56-8.56, P <0.0001), ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the stocks Jim Cramer recently shed light on. When a caller noted that the ...

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

The report, from 340B Health, claims that changes proposed by major drugmakers to replace upfront discounts with post-sale rebates for outpatient drugs would hit safety-net hospitals with significant ...

With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

Acute Ischemic Stroke companies working in the treatment market are Acticor Biotech, Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, Abbvie, and others, are developing therapies for ...

Even though oncology segment revenue inched up just 1 percent year over year, the firm lifted full-year expectations slightly ...

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.